Oculus Innovative Sciences Inc. (NASDAQ:OCLS) dropped 4.4% during trading on Thursday . The stock traded as low as $4.26 and last traded at $4.35, with a volume of 90,406 shares changing hands. The stock had previously closed at $4.55.

Separately, Maxim Group restated a “buy” rating and issued a $7.00 target price on shares of Oculus Innovative Sciences in a research note on Thursday, August 11th.

The firm’s market capitalization is $18.86 million. The stock’s 50-day moving average price is $4.13 and its 200-day moving average price is $4.67.

Oculus Innovative Sciences (NASDAQ:OCLS) last posted its quarterly earnings results on Thursday, July 28th. The company reported ($0.61) earnings per share for the quarter. Equities analysts predict that Oculus Innovative Sciences Inc. will post ($2.04) EPS for the current fiscal year.

Oculus Innovative Sciences, Inc is a specialty pharmaceutical company, which focuses on identifying, developing and commercializing therapies to manage the lives of patients with dermatologic diseases or conditions. The Company’s products treat certain topical skin diseases, including acne, atopic dermatitis, scarring, infections, itch, pain and inflammatory responses.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.